{"id":1843,"date":"2019-02-11T17:31:20","date_gmt":"2019-02-11T14:31:20","guid":{"rendered":"http:\/\/ars-patent.co.uk\/de\/?p=1843"},"modified":"2019-05-16T11:08:16","modified_gmt":"2019-05-16T08:08:16","slug":"kirill-osipov-commented-on-the-recent-invalidation-of-another-patent-of-russian-generic-producer-nativa","status":"publish","type":"post","link":"https:\/\/ars-patent.com\/de\/kirill-osipov-commented-on-the-recent-invalidation-of-another-patent-of-russian-generic-producer-nativa\/","title":{"rendered":"Kirill Osipov commented on the recent invalidation of yet another patent of Russian generic producer Nativa"},"content":{"rendered":"<p>Pharmaceutical Bulletin \u2013 one of the largest professional magazines devoted to Russian pharma \u2013 published an article on the recent invalidation of yet another patent of Nativa. Nativa is a Russian generic producer, infamous for its involvement in numerous patent infringement cases with the largest originator makers. Nativa&#8217;s patent, rendered invalid in the end of January, was for invention claimed to be dependent on the substance patented by Bristol-Myers Squibb\u00a0and used in the production of Sprycel.<\/p>\n<p>The Head of Legal Department of ARS-Patent <a href=\"http:\/\/ars-patent.co.uk\/de\/our-team\/attorneys\/kirill-osipov\/\" target=\"_blank\" rel=\"noopener\">Kirill Osipov<\/a> provided his comments to Pharmaceutical Bulletin on the case and the acute problem of dependent inventions in general.<\/p>\n<p>The full article is available <a href=\"https:\/\/pharmvestnik.ru\/content\/news\/Nativa-poteryala-eshe-odin-patent.html\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmaceutical Bulletin \u2013 one of the largest professional magazines devoted to Russian pharma \u2013 published an article on the recent invalidation of yet another patent of Nativa. Nativa is a Russian generic producer, infamous for its involvement in numerous patent infringement cases with the largest originator makers. Nativa&#8217;s patent, rendered invalid in the end of [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[19],"tags":[],"post-type":[12],"class_list":["post-1843","post","type-post","status-publish","format-standard","hentry","category-news-and-events","post-type-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/posts\/1843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/comments?post=1843"}],"version-history":[{"count":9,"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/posts\/1843\/revisions"}],"predecessor-version":[{"id":1902,"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/posts\/1843\/revisions\/1902"}],"wp:attachment":[{"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/media?parent=1843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/categories?post=1843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/tags?post=1843"},{"taxonomy":"post-type","embeddable":true,"href":"https:\/\/ars-patent.com\/de\/wp-json\/wp\/v2\/post-type?post=1843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}